Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on FormS-8 of our report dated March 13, 2020 (June 8, 2020, as to effects of the reverse stock split discussed in Note 16) relating to the financial statements of Vaxcyte, Inc., appearing in Registration StatementNo. 333-238630 on FormS-1 of Vaxcyte, Inc.
/s/ Deloitte & Touche LLP |
San Francisco, California |
June 12, 2020 |